These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37821271)

  • 21. Characterising body composition and bone health in transgender individuals receiving gender-affirming hormone therapy.
    Ford K; Huggins E; Sheean P
    J Hum Nutr Diet; 2022 Dec; 35(6):1105-1114. PubMed ID: 35509260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovarian, breast, and metabolic changes induced by androgen treatment in transgender men.
    Pirtea P; Ayoubi JM; Desmedt S; T'Sjoen G
    Fertil Steril; 2021 Oct; 116(4):936-942. PubMed ID: 34481638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contraception across the transmasculine spectrum.
    Krempasky C; Harris M; Abern L; Grimstad F
    Am J Obstet Gynecol; 2020 Feb; 222(2):134-143. PubMed ID: 31394072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transgender health and the impact of aging and menopause.
    Cheung AS; Nolan BJ; Zwickl S
    Climacteric; 2023 Jun; 26(3):256-262. PubMed ID: 37011669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breakthrough Bleeding in Transgender and Gender Diverse Adolescents and Young Adults on Long-Term Testosterone.
    Grimstad F; Kremen J; Shim J; Charlton BM; Boskey ER
    J Pediatr Adolesc Gynecol; 2021 Oct; 34(5):706-716. PubMed ID: 33910088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac Mechanics in Altered Hormonal States as a Surrogate for Understanding the Effects of Transgender Hormone Therapy.
    Moudgal R; Peritz DC; Turco J; Taub C
    Cardiol Rev; 2024 Jan-Feb 01; 32(1):75-82. PubMed ID: 35950948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipid profiles and hypertriglyceridemia among transgender and gender diverse adults on gender-affirming hormone therapy.
    Leemaqz SY; Kyinn M; Banks K; Sarkodie E; Goldstein D; Irwig MS
    J Clin Lipidol; 2023; 17(1):103-111. PubMed ID: 36473821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transgender healthcare: metabolic outcomes and cardiovascular risk.
    Glintborg D; Christensen LL; Andersen MS
    Diabetologia; 2024 Jul; ():. PubMed ID: 38958699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Gender-Affirming Hormone Therapy With Depression, Thoughts of Suicide, and Attempted Suicide Among Transgender and Nonbinary Youth.
    Green AE; DeChants JP; Price MN; Davis CK
    J Adolesc Health; 2022 Apr; 70(4):643-649. PubMed ID: 34920935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Which U.S. States' Medicaid Programs Provide Coverage for Gender-Affirming Hormone Therapy and Gender-Affirming Genital Surgery for Transgender Patients?: A State-by-State Review, and a Study Detailing the Patient Experience to Confirm Coverage of Services.
    Zaliznyak M; Jung EE; Bresee C; Garcia MM
    J Sex Med; 2021 Feb; 18(2):410-422. PubMed ID: 33422448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gender-affirming hormone therapy and the risk of sex hormone-dependent tumours in transgender individuals-A systematic review.
    McFarlane T; Zajac JD; Cheung AS
    Clin Endocrinol (Oxf); 2018 Dec; 89(6):700-711. PubMed ID: 30107028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombosis Risk in Transgender Adolescents Receiving Gender-Affirming Hormone Therapy.
    Mullins ES; Geer R; Metcalf M; Piccola J; Lane A; Conard LAE; Mullins TLK
    Pediatrics; 2021 Apr; 147(4):. PubMed ID: 33753543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Effect of Gender-Affirming Hormone Therapy on the Risk of Subclinical Atherosclerosis in the Transgender Population: A Systematic Review.
    Moreira Allgayer RMC; Borba GDS; Moraes RS; Ramos RB; Spritzer PM
    Endocr Pract; 2023 Jun; 29(6):498-507. PubMed ID: 36603652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Androgenetic alopecia incidence in transgender and gender diverse populations: A retrospective comparative cohort study.
    Gao JL; Sanz J; Tan N; King DS; Modest AM; Dommasch ED
    J Am Acad Dermatol; 2023 Sep; 89(3):504-510. PubMed ID: 36780950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expanding upon the relationship between gender-affirming hormone therapy, neural connectivity, mental health, and body image dissatisfaction.
    Grannis C; Mattson WI; Leibowitz SF; Nahata L; Chen D; Strang JF; Thobe H; Indyk JA; Nelson EE
    Psychoneuroendocrinology; 2023 Oct; 156():106319. PubMed ID: 37331310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effect of Gender-Affirming Hormone Therapy on Serum Creatinine in Transgender Individuals.
    Maheshwari A; Dines V; Saul D; Nippoldt T; Kattah A; Davidge-Pitts C
    Endocr Pract; 2022 Jan; 28(1):52-57. PubMed ID: 34474185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gender-affirming hormone therapy induces specific DNA methylation changes in blood.
    Shepherd R; Bretherton I; Pang K; Mansell T; Czajko A; Kim B; Vlahos A; Zajac JD; Saffery R; Cheung A; Novakovic B
    Clin Epigenetics; 2022 Feb; 14(1):24. PubMed ID: 35177097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics and gender affirming healthcare needs of transgender and non-binary students starting hormone therapy in a student health service in Aotearoa New Zealand.
    Carroll R; Sepulveda B; McLeod L; Stephenson C; Carroll RW
    J Prim Health Care; 2023 Jun; 15(2):106-111. PubMed ID: 37390028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biopsychosocial Mechanisms Linking Gender Minority Stress to HIV Comorbidities Among Black and Latina Transgender Women (LITE Plus): Protocol for a Mixed Methods Longitudinal Study.
    Rich AJ; Williams J; Malik M; Wirtz A; Reisner S; DuBois LZ; Juster RP; Lesko CR; Davis N; Althoff KN; Cannon C; Mayer K; Elliott A; Poteat T
    JMIR Res Protoc; 2020 Apr; 9(4):e17076. PubMed ID: 32281542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gender-affirming hormones and surgery in transgender children and adolescents.
    Mahfouda S; Moore JK; Siafarikas A; Hewitt T; Ganti U; Lin A; Zepf FD
    Lancet Diabetes Endocrinol; 2019 Jun; 7(6):484-498. PubMed ID: 30528161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.